首页 | 本学科首页   官方微博 | 高级检索  
检索        

临床新技术激励与约束机制初探
引用本文:吴娅利,陈黎明,张恩全,辇伟奇,刘国祥,罗长坤.临床新技术激励与约束机制初探[J].中国卫生质量管理,2010,17(3):13-14.
作者姓名:吴娅利  陈黎明  张恩全  辇伟奇  刘国祥  罗长坤
作者单位:第三军医大学训练部临床管理处,重庆,400038
摘    要:鼓励与约束机制是临床新技术管理的两个方面。根据临床新技术开展的不同阶段,采取不同的激励措施。科学的约束机制是激励措施的重要前提。应注意避免3个问题:激励庸俗化、管理机械化、激励和管理对立化。

关 键 词:临床新技术  激励  规范

The Incentive and Restriction Mechanism of New Clinical Techniques
Institution:WU Yali, CHEN Liming, ZHANG Enquan, et al. ( Clinical Management Office, Department of Training, Third Military Medical University, Chongqing, 400038, China)
Abstract:The encouragement and restriction mechanism is the two aspects of new clinical technology management. Based on the different stages of new clinical technology, different incentive measures should be carried out ; and scientific restraint mechanism is an important prerequisite for incentives measures. There are three problems should be avoided: vulgarization of incentive, mechanization of management, opposition between incentive and management.
Keywords:New Clinical Techniques  Incentive  Specification
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号